Literature DB >> 2211671

Purification and expression of gCap39. An intracellular and secreted Ca2(+)-dependent actin-binding protein enriched in mononuclear phagocytes.

P A Johnston1, F X Yu, G A Reynolds, H L Yin, C R Moomaw, C A Slaughter, T C Südhof.   

Abstract

A protein of approximately 40 kDa was the major Ca2(+)-binding protein purified by Ca2(+)-dependent hydrophobic affinity chromatography from the cell lysates and conditioned media of RAW macrophages. Other Ca2(+)-binding proteins, including several annexins (calelectrins), S100-like proteins, and calmodulin, were less abundant and preferentially found in the cell lysates. Amino acid sequences of tryptic fragments from the purified 40-kDa protein revealed its identity to gCap39, an actin-binding protein encoded by a cDNA isolated on the basis of its homology with gelsolin. When an expression vector containing the gCap39 coding region was transfected into COS cells, high levels of gCap39 were found in both the cells and conditioned media, whereas annexins were only present in the cells. gCap39 could also be purified from human plasma where it appeared to be a minor component. No signal sequence was detected in the primary structure of gCap39 and the secreted and intracellular forms of gCap39 are of identical size, suggesting that unlike gelsolin, the mechanism of gCap39 secretion may not depend on a signal sequence. The high concentration of gCap39 in macrophages and its constitutive secretion as well as intracellular retention suggest that this protein may have a dual role in macrophage function, namely that of a Ca2(+)- and polyphosphoinositide-regulated intracellular modulator of the cytoskeleton as well as that of a secreted protein involved in the clearance of actin from the extracellular environment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211671

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Tetracycline-inducible protein expression in pancreatic cancer cells: effects of CapG overexpression.

Authors:  Sarah Tonack; Sabina Patel; Mehdi Jalali; Taoufik Nedjadi; Rosalind E Jenkins; Christopher Goldring; John Neoptolemos; Eithne Costello
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

2.  Gelsolin, a protein that caps the barbed ends and severs actin filaments, enhances the actin-based motility of Listeria monocytogenes in host cells.

Authors:  R O Laine; K L Phaneuf; C C Cunningham; D Kwiatkowski; T Azuma; F S Southwick
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

3.  Direct observation of actin filament severing by gelsolin and binding by gCap39 and CapZ.

Authors:  E L Bearer
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

4.  Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer.

Authors:  Senwei Jiang; Yuebo Yang; Yu Zhang; Qingjian Ye; Jiao Song; Min Zheng; Xiaomao Li
Journal:  Dis Markers       Date:  2022-02-09       Impact factor: 3.434

5.  Physarum actin is phosphorylated as the actin-fragmin complex at residues Thr203 and Thr202 by a specific 80 kDa kinase.

Authors:  J Gettemans; Y De Ville; J Vandekerckhove; E Waelkens
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

6.  Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity.

Authors:  Hitomi Nomura; Katsuhiro Uzawa; Takashi Ishigami; Yukinao Kouzu; Hirofumi Koike; Katsunori Ogawara; Masashi Siiba; Hiroki Bukawa; Hidetaka Yokoe; Hitoshi Kubosawa; Hideki Tanzawa
Journal:  BMC Cancer       Date:  2008-02-01       Impact factor: 4.430

7.  CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription.

Authors:  Sheng Huang; Yayun Chi; Yi Qin; Ziliang Wang; Bingqiu Xiu; Yonghui Su; Rong Guo; Liang Guo; Hefen Sun; Chujia Zeng; Shuling Zhou; Xin Hu; Sheng Liu; Zhimin Shao; Zhaohui Wu; Wei Jin; Jiong Wu
Journal:  Theranostics       Date:  2018-04-03       Impact factor: 11.556

8.  CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50.

Authors:  Yayun Chi; Jingyan Xue; Sheng Huang; Bingqiu Xiu; Yonghui Su; Wei Wang; Rong Guo; Lei Wang; Lun Li; Zhiming Shao; Wei Jin; Zhaohui Wu; Jiong Wu
Journal:  Theranostics       Date:  2019-09-21       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.